The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
Learn how to license this index| Component | Country | Weight |
|---|---|---|
| WAVE LIFE SCIENCES PTE LTD | SG | 4.42% |
| ANAVEX LIFE SCIENCES CORP | US | 3.57% |
| VERACYTE INC | US | 2.57% |
| ADAPTIVE BIOTECHNOLOGIES CORP | US | 2.54% |
| ALNYLAM PHARMACEUTICALS INC | US | 2.51% |
| CAREDX INC | US | 2.26% |
| CARSGEN THERAPEUTICS HOLDING | KY | 2.20% |
| CASTLE BIOSCIENCES INC | US | 2.08% |
| AVIDITY BIOSCIENCES INC | US | 2.04% |
| ILLUMINA INC | US | 2.02% |
Gain access to all index Data and Services. Receive update on market developments, index news and corporate announcements.
Sign up nowAlready have an account? Log in here
Country weightings are based on the weightings of all index components in a certain country.
| Country | Components | Weight |
|---|---|---|
| United States | 54 | 73.21% |
| Netherlands | 5 | 6.85% |
| United Kingdom | 3 | 5.62% |
| Singapore | 1 | 4.42% |
| Cayman Islands | 2 | 3.94% |
| Japan | 1 | 1.65% |
| Germany | 1 | 1.61% |
| Belgium | 1 | 1.56% |
| Switzerland | 1 | 1.16% |
| Total | 69 | 100.00% |
Sector weightings are based on the weightings of all index components in a certain sector.
| Sector | Components | Weight |
|---|---|---|
| Health Care | 68 | 99.39% |
| Materials | 1 | 0.61% |
| Total | 69 | 100.00% |
| Size | Market Cap | Components | Weight |
|---|---|---|---|
| Large-Cap | 368,191,248,000 USD | 11 | 17.04% |
| Mid-Cap | 65,322,790,900 USD | 21 | 35.35% |
| Small-Cap | 22,259,393,440 USD | 37 | 47.60% |
| Micro-Cap | - | - | - |
| Total | 455,773,432,340 USD | 69 | 100.00% |
A license agreement is required to use MarketVector indexes, index data or trademarks for various commercial purpose. These include research and analysis, as well as the creation, introduction, promotion, or marketing of financial products such as exchange-traded products, mutual funds, certificates, derivatives, swaps, bonds, or OTC products connected to or derived from MarketVectorTM Indexes.
We can help you learn more about acquiring a suitable license for your needs.